These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 34643714)

  • 1. Humoral response after SARS-CoV-2 vaccination in patients undergoing maintenance haemodialysis: loss of immunity, third dose and non-responders.
    Robert T; Lano G; Giot M; Fourié T; de Lamballeri X; Jehel O; Bouchouareb D; Brunet P; Ninove L; Burtey S
    Nephrol Dial Transplant; 2022 Jan; 37(2):390-392. PubMed ID: 34643714
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.
    Schrezenmeier E; Bergfeld L; Hillus D; Lippert JD; Weber U; Tober-Lau P; Landgraf I; Schwarz T; Kappert K; Stefanski AL; Sattler A; Kotsch K; Dörner T; Sander LE; Budde K; Halleck F; Kurth F; Corman VM; Choi M
    Front Immunol; 2021; 12():690698. PubMed ID: 34276681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum.
    Quiroga B; Soler MJ; Ortiz A; Orero E; Tejedor S; Mantecón CJJ; Gómez Pérez VO; Marín Franco AJ; Alfaro Sánchez C; Puerta Carretero M; Jaldo Rodríguez MT; Carnerero Di Riso MA; Martínez S; González CC; Cervienka M; Macías Carmona N; Arroyo D; Pérez Del Valle KM; de Arriba G; Mazuecos A; Cazorla JM; Pereira M; González Parra E; Sánchez Márquez MG; Lancho Novillo C; Toyos Ruiz C; Aguilar Cervera MC; Muñoz Ramos P; Sánchez Horrillo A; Jimeno Martín I; Toapanta N; Cigarrán Guldris S; Folgueiras López M; Valero San Cecilio R; Villacorta Linaza B; Minguela Pesquera I; Santana Estupiñán R; Zamora R; Soriano S; Muñoz de Bustillo E; Pizarro Sánchez MS; Martínez Puerto AI; Yugueros A; Muñiz Pacios L; Leyva A; Rojas J; Gansevoort RT; de Sequera P;
    Clin J Am Soc Nephrol; 2022 Jun; 17(6):872-876. PubMed ID: 35551070
    [No Abstract]   [Full Text] [Related]  

  • 4. Waning humoral response 6 months after SARS-CoV-2 vaccination with the mRNA-BNT162b2 vaccine in hemodialysis patients: time for a boost.
    Davidovic T; Schimpf J; Abbassi-Nik A; Stockinger R; Sprenger-Mähr H; Lhotta K; Zitt E
    Kidney Int; 2021 Dec; 100(6):1334-1335. PubMed ID: 34656642
    [No Abstract]   [Full Text] [Related]  

  • 5. High immunogenicity of a messenger RNA-based vaccine against SARS-CoV-2 in chronic dialysis patients.
    Longlune N; Nogier MB; Miedougé M; Gabilan C; Cartou C; Seigneuric B; Del Bello A; Marion O; Faguer S; Izopet J; Kamar N
    Nephrol Dial Transplant; 2021 Aug; 36(9):1704-1709. PubMed ID: 34057463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.
    Gil-Manso S; Carbonell D; López-Fernández L; Miguens I; Alonso R; Buño I; Muñoz P; Ochando J; Pion M; Correa-Rocha R
    Front Immunol; 2021; 12():726960. PubMed ID: 34671348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Equivalent humoral and cellular immune response but different side effect rates following SARS-CoV-2 vaccination in peritoneal and haemodialysis patients using messenger RNA vaccines.
    Stumpf J; Klimova A; Mauer R; Steglich A; Gembardt F; Martin H; Glombig G; Frank K; Tonn T; Hugo C
    Nephrol Dial Transplant; 2022 Mar; 37(4):796-798. PubMed ID: 34791446
    [No Abstract]   [Full Text] [Related]  

  • 8. Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
    Carr EJ; Wu M; Harvey R; Wall EC; Kelly G; Hussain S; Howell M; Kassiotis G; Swanton C; Gandhi S; Bauer DL; ; ; Billany RE; Graham-Brown MP; Beckett J; Bull K; Shankar S; Henderson S; Motallebzadeh R; Salama AD; Harper L; Mark PB; McAdoo S; Willicombe M; Beale R
    Lancet; 2021 Sep; 398(10305):1038-1041. PubMed ID: 34391504
    [No Abstract]   [Full Text] [Related]  

  • 9. Measuring cellular and humoral immunogenicity of a SARS-CoV-2 mRNA vaccine (BNT126b2) in patients on maintenance haemodialysis.
    Martin P; Clarke C
    EBioMedicine; 2021 Sep; 71():103567. PubMed ID: 34454401
    [No Abstract]   [Full Text] [Related]  

  • 10. SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis.
    Bensouna I; Caudwell V; Kubab S; Acquaviva S; Pardon A; Vittoz N; Bozman DF; Hanafi L; Faucon AL; Housset P
    Am J Kidney Dis; 2022 Feb; 79(2):185-192.e1. PubMed ID: 34508833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodialysis patients show a highly diminished antibody response after COVID-19 mRNA vaccination compared with healthy controls.
    Simon B; Rubey H; Treipl A; Gromann M; Hemedi B; Zehetmayer S; Kirsch B
    Nephrol Dial Transplant; 2021 Aug; 36(9):1709-1716. PubMed ID: 33999200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar humoral immune responses in peritoneal dialysis and haemodialysis patients after two doses of the SARS-CoV-2 vaccine BNT162b2.
    Patecki M; Merscher S; Dumann H; Bernhardt W; Dopfer-Jablonka A; Cossmann A; Stankov MV; Einecke G; Haller H; Schlieper G; Behrens GM
    Perit Dial Int; 2022 Jan; 42(1):100-101. PubMed ID: 34753339
    [No Abstract]   [Full Text] [Related]  

  • 14. A prospective observational study for justification, safety, and efficacy of a third dose of mRNA vaccine in patients receiving maintenance hemodialysis.
    Espi M; Charmetant X; Barba T; Mathieu C; Pelletier C; Koppe L; Chalencon E; Kalbacher E; Mathias V; Ovize A; Cart-Tanneur E; Bouz C; Pellegrina L; Morelon E; Juillard L; Fouque D; Couchoud C; Thaunat O;
    Kidney Int; 2022 Feb; 101(2):390-402. PubMed ID: 34856313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response after different SARS-CoV-2 vaccination regimens.
    Rose R; Neumann F; Grobe O; Lorentz T; Fickenscher H; Krumbholz A
    BMC Med; 2022 Jan; 20(1):31. PubMed ID: 35057798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ROMANOV study found impaired humoral and cellular immune responses to SARS-CoV-2 mRNA vaccine in virus-unexposed patients receiving maintenance hemodialysis.
    Espi M; Charmetant X; Barba T; Koppe L; Pelletier C; Kalbacher E; Chalencon E; Mathias V; Ovize A; Cart-Tanneur E; Bouz C; Pellegrina L; Morelon E; Fouque D; Juillard L; Thaunat O
    Kidney Int; 2021 Oct; 100(4):928-936. PubMed ID: 34284044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to: Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli
    Bonelli M; Aletaha D
    Ann Rheum Dis; 2021 Oct; 80(10):e167. PubMed ID: 34340982
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral response to vaccination against SARS-CoV-2 in patients undergoing maintenance hemodialysis.
    Delgado Ureña A; Hernández García E; Varillas Caso DA
    Med Clin (Barc); 2023 Apr; 160(7):321-322. PubMed ID: 36577651
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign.
    Ferrari D; Mangia A; Spanò MS; Zaffarano L; Viganò M; Di Resta C; Locatelli M; Ciceri F; De Vecchi E
    Clin Chem Lab Med; 2021 Nov; 59(12):2019-2026. PubMed ID: 34614550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients.
    Broseta JJ; Rodríguez-Espinosa D; Bedini JL; Rodríguez N; Maduell F
    Nephrol Dial Transplant; 2021 Dec; 36(12):2340-2341. PubMed ID: 34534347
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.